This week is relatively light regarding data coming out from countries. However, investors and traders will be focusing on one essential item – clarification on the Pfizer vaccine’s efficacy and timeline. Anthony Fauci stated that the Pfizer vaccine has an “extraordinarily high degree of efficacy – more than 90%, close to 95%” and that the U.S. may begin offering the vaccine to priority groups at the end of December. This hope of a vaccine before year-end boosted risk on sentiment last week. But further clarification of the vaccine’s timeline may solidify its move upwards, not to mention an additional step back to normalcy in the world.